The Number of Lateral Hypothalamus Orexin/hypocretin Neurons Contributes to Individual Differences in Cocaine Demand

Overview

Journal Addict Biol

Specialty Psychiatry

Date 2019 Jul 13

PMID 31297913

Citations 25

Authors

Caroline B Pantazis

Morgan H James

Brandon S Bentzley

Gary Aston-Jones

Affiliations

Soon will be listed here.

Abstract

Lateral hypothalamus (LH) orexin neuron signaling has been implicated in the motivation to seek and take drugs of abuse. The number of LH orexin neurons has been shown to be upregulated with exposure to drugs of abuse. We sought to determine if the number of LH orexin neurons related to individual differences in motivation (demand) for cocaine in our behavioral economics (BE) paradigm, and whether knockdown of these cells predicted changes in economic demand. We quantified LH orexin cell numbers in animals immediately following our BE paradigm, as well as after a 2-week period of abstinence, to relate the number of LH orexin cells to economic demand for cocaine. We also knocked down LH orexin expression with an orexin morpholino antisense to determine how reduced orexin numbers impacted cocaine demand. We found that animals with greater baseline motivation for cocaine (lower demand elasticity) had more LH orexin neurons. Following a 2-week abstinence from cocaine, the number of LH orexin neurons predicted economic demand for cocaine prior to abstinence, indicating that orexin expression is a persistent marker for demand. Reducing LH orexin cell numbers with antisense decreased motivation for cocaine (increased demand elasticity) without affecting baseline consumption. In addition, the number of spared LH orexin neurons after antisense treatment correlated with individual motivation for cocaine. These studies point to a role for the endogenous number of LH orexin neurons in individual differences in motivation for cocaine.

Citing Articles

The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans.

Malungo I, Ngwenya A, Bertelsen M, Spocter M, Thannickal T, Siegel J J Comp Neurol. 2025; 533(2):e70032.

PMID: 40008540 PMC: 11863299. DOI: 10.1002/cne.70032.

Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults.

Equihua-Benitez A, Espinoza-Abad R, Garcia-Garcia F Behav Sci (Basel). 2025; 15(2).

PMID: 40001851 PMC: 11852296. DOI: 10.3390/bs15020220.

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation.

Mohammadkhani A, Mitchell C, James M, Borgland S, Dayas C Br J Pharmacol. 2024; 181(22):4430-4449.

PMID: 39317446 PMC: 11458361. DOI: 10.1111/bph.17325.

Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior.

Illenberger J, Flores-Ramirez F, Pascasio G, Franco M, Mendonsa B, Martin-Fardon R J Psychopharmacol. 2024; 38(7):647-660.

PMID: 38888086 PMC: 11407285. DOI: 10.1177/02698811241260989.

Habitual behaviour associated with exposure to high-calorie diet is prevented by an orexin-receptor-1 antagonist.

Merlin S, Furlong T Addict Neurosci. 2023; 4.

PMID: 37476304 PMC: 10357952. DOI: 10.1016/j.addicn.2022.100036.

References

Mahler S, Smith R, Aston-Jones G . Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl). 2012; 226(4):687-98. PMC: 3649073. DOI: 10.1007/s00213-012-2681-5. View

Harris G, Wimmer M, Aston-Jones G . A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005; 437(7058):556-9. DOI: 10.1038/nature04071. View

Gonzalez J, Jensen L, Fugger L, Burdakov D . Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci. 2012; 35(9):1426-32. PMC: 5767120. DOI: 10.1111/j.1460-9568.2012.08057.x. View

Harris G, Aston-Jones G . Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 2006; 29(10):571-7. DOI: 10.1016/j.tins.2006.08.002. View

James M, Stopper C, Zimmer B, Koll N, Bowrey H, Aston-Jones G . Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats. Biol Psychiatry. 2018; 85(11):925-935. PMC: 7528037. DOI: 10.1016/j.biopsych.2018.07.022. View

de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View

Reissner K, Sartor G, Vazey E, Dunn T, Aston-Jones G, Kalivas P . Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods. 2011; 203(2):354-60. PMC: 3857614. DOI: 10.1016/j.jneumeth.2011.10.009. View

Steiner N, Rossetti C, Sakurai T, Yanagisawa M, De Lecea L, Magistretti P . Hypocretin/orexin deficiency decreases cocaine abuse liability. Neuropharmacology. 2018; 133:395-403. DOI: 10.1016/j.neuropharm.2018.02.010. View

Lopez M, Moorman D, Aston-Jones G, Becker H . The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res. 2016; 1636:74-80. PMC: 4808605. DOI: 10.1016/j.brainres.2016.01.049. View

10.

Moorman D, Aston-Jones G . Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats. Alcohol. 2009; 43(5):379-86. PMC: 2741398. DOI: 10.1016/j.alcohol.2009.07.002. View

11.

Baimel C, Lau B, Qiao M, Borgland S . Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons. Cell Rep. 2017; 18(6):1346-1355. DOI: 10.1016/j.celrep.2017.01.030. View

12.

Hollander J, Pham D, Fowler C, Kenny P . Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci. 2012; 6:47. PMC: 3402880. DOI: 10.3389/fnbeh.2012.00047. View

13.

Hursh S, Silberberg A . Economic demand and essential value. Psychol Rev. 2008; 115(1):186-98. DOI: 10.1037/0033-295X.115.1.186. View

14.

Mahler S, Aston-Jones G . Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats. J Neurosci. 2012; 32(38):13309-26. PMC: 3480730. DOI: 10.1523/JNEUROSCI.2277-12.2012. View

15.

Moorman D, James M, Kilroy E, Aston-Jones G . Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner. Eur J Neurosci. 2016; 43(5):710-20. PMC: 4783285. DOI: 10.1111/ejn.13170. View

16.

Bentzley B, Fender K, Aston-Jones G . The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures. Psychopharmacology (Berl). 2012; 226(1):113-25. PMC: 3572328. DOI: 10.1007/s00213-012-2899-2. View

17.

Mahler S, Smith R, Moorman D, Sartor G, Aston-Jones G . Multiple roles for orexin/hypocretin in addiction. Prog Brain Res. 2012; 198:79-121. PMC: 3643893. DOI: 10.1016/B978-0-444-59489-1.00007-0. View

18.

James M, Charnley J, Levi E, Jones E, Yeoh J, Smith D . Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol. 2011; 14(5):684-90. DOI: 10.1017/S1461145711000423. View

19.

James M, Mahler S, Moorman D, Aston-Jones G . A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?. Curr Top Behav Neurosci. 2016; 33:247-281. PMC: 5799809. DOI: 10.1007/7854_2016_57. View

20.

Espana R, Melchior J, Roberts D, Jones S . Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl). 2010; 214(2):415-26. PMC: 3085140. DOI: 10.1007/s00213-010-2048-8. View